Devi et al. argue that two technological barriers β the diffraction-limited size of centrosomes and their insoluble, single-copy nature β historically blocked molecular dissection of centrosomes, primary cilia, and centriolar satellites, and that super-resolution imaging plus proximity labeling (BioID) circumvented both . The strongest quantitative content is the reported resolution hierarchy (3D-SIM axial 100 nm/lateral 300 nm; STED 130/50 nm; SMLM 50/20 nm; ExM ~70 nm lateral from a conventional microscope) and the BioID 10 nm labeling radius, with first-generation BioID requiring ~18 h labeling versus 10 min for TurboID β a temporal-resolution limit the review itself flags as its main methodological weakness .
Axial value for conventional microscopy is the 500-800 nm range midpoint as stated in Box 1; ExM axial was not reported. Bars are lower-is-better resolution limits, not biological measurements.
The two landmark datasets the review anchors on are a 58-bait centrosome BioID map (>1700 unique proteins, >7000 proximity interactions) and a 22-bait satellite interactome (2113 interactions among 660 proteins, ~40% overlap with the centrosome interactome) . A critical reader must note the review's own caveat: biotinylation marks proximity, not physical binding β a proximity partner may be a direct interactor, an indirect one, or merely nearby . The 18-h labeling window also smears dynamic, cell-cycle-dependent interactions, which the review acknowledges and proposes TurboID/AirID to fix. Subsequent work confirms both the value and the smearing problem: 2024-2025 proximity-labeling studies in human cells and Drosophila refined the satellite landscape far beyond cargo trafficking, showing satellites concentrate nascent translation of centrosomal/ciliary mRNAs , assemble hierarchically from PCM1 , and exist even in C. elegans as condensate-like SAS-1/SSNA-1 foci .
Strengths. The review is honest about method limits (proximity β binding; ExM artifacts; BioID temporal smearing), declares no conflicts of interest, and correctly predicted that faster enzymes (TurboID, AirID) and cross-species application would drive the next wave β validated by the 2024-2026 literature .
Blind spots. First, the review frames satellites mainly as trafficking modules; the translation-hub and sequestration-of-degradation-factor functions now look equally central . Second, it under-weights cell-type and species heterogeneity: much of the cited interactome work used a handful of lines (RPE1, HeLa, U2OS), while subsequent work shows satellite localization differs drastically between vertebrates and Drosophila . Third, classical structural insights (e.g., BBS4-PCM1-dynein transport and the PCM1-centric satellite definition ) are presented somewhat teleologically; alternative models β satellites as phase-separated condensates whose apparent 'transport' reflects condensate dynamics β were only beginning to be tested and are now supported .
Falsification and confidence. The central technological thesis (super-resolution + proximity labeling resolves these organelles) would be weakened if newer direct-interaction methods (crosslinking MS, cryo-ET) showed BioID maps systematically misassign compartment membership. I rate the review's factual synthesis high-confidence; its functional framing of satellites as primarily trafficking is now only moderate-confidence given the translation-hub evidence. What would change this assessment: a cell-type-resolved TurboID atlas showing trafficking, not translation, dominates satellite output in primary ciliated cells.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.